Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Advanced Oncotherapy
Life Sciences
Confidence in LIGHT gaining momentum
By
Dr Martin Hall
17 Feb 2020
Chamberlin Plc
Industrial
Near-term trading subdued
By
Paul Singer
17 Feb 2020
International Lithium Corp.
Mining
Resource upgrade and happy strategic dilemma
By
Paul Mylchreest
10 Feb 2020
Tissue Regenix
Life Sciences
Restructured to satisfy product demand
06 Feb 2020
Renewables
UK Renewable Energy Infrastructure Funds
By
Nigel Hawkins
05 Feb 2020
genedrive Plc
Life Sciences
Western market progress but developing markets difficult
05 Feb 2020
Share ownership: for the many, not the few – The sequel
By
Keith Hiscock
04 Feb 2020
Volta Finance
Investment Companies
Follow the money
By
Mark Thomas
03 Feb 2020
The Monthly: February 2020
03 Feb 2020
Mining
Gold: Open Letter to LBMA Board of Directors
By
Paul Mylchreest
29 Jan 2020
Shield Therapeutics Plc
Life Sciences
Good demand for Feraccru in Europe
By
Dr Martin Hall
28 Jan 2020
Prev
1
...
47
48
49
50
51
...
84
Next
